SAB Biotherapeutics Inc

SAB Biotherapeutics Inc(SABS)价格预测

$3.180

+0.061 (+1.92%)收盘时

价格预测

1-Day Price Prediction
-0.24%
1-Week Prediction
+0.88%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中打开以解锁更长周期的预测。

Loading chart…

SABS 相似图表分析预测

Alphio's SABS stock price prediction model matches the current SAB Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.17 (-0.24%). The 1-week path is $3.21 (+0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 SAB Biotherapeutics Inc 股票吗?

SAB Biotherapeutics Inc is a good buy right now due to its current price of $3.30, which is significantly below the analyst price targets of $11 and $13. The stock has shown a strong recent performance with a 5-day change of +18.28%, indicating positive momentum. However, the primary risk is the company's ongoing net losses, with a reported net loss of $18.9 million for Q1 2026, which raises concerns about its financial health.

SABS 股价于 Wednesday 收于 $3.18,此前上涨 +1.92%

SAB Biotherapeutics Inc (SABS) last closed at $3.1800001, gaining +1.92%. These facts feed the 1-day and 1-week SABS price prediction above.

预测驱动因素

SAB Biotherapeutics Inc(SABS)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 SABS 最接近的股票,按相似度排序。

SABS 季节性分析

Historically the probability of a positive November return for SABS is 19.05%. December offers the highest probability of a positive month at 37.21%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易